Baillie Gifford & Co - Net Worth and Insider Trading

Baillie Gifford & Co Net Worth

The estimated net worth of Baillie Gifford & Co is at least $216 Million dollars as of 2024-09-29. Baillie Gifford & Co is the 2102 Investment manager of Hangzhou Tigermed Consulting Co Ltd and owns about 6,167,700 shares of Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) stock worth over $216 Million. Details can be seen in Baillie Gifford & Co's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Baillie Gifford & Co has not made any transactions after 2022-02-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Baillie Gifford & Co

To

Baillie Gifford & Co Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Baillie Gifford & Co owns 1 companies in total, including Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) .

Click here to see the complete history of Baillie Gifford & Co’s form 4 insider trades.

Insider Ownership Summary of Baillie Gifford & Co

Ticker Comapny Transaction Date Type of Owner
HKSE:03347 Hangzhou Tigermed Consulting Co Ltd 2022-02-04 2102 Investment manager

Baillie Gifford & Co Latest Holdings Summary

Baillie Gifford & Co currently owns a total of 1 stock. Baillie Gifford & Co owns 6,167,700 shares of Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) as of February 4, 2022, with a value of $216 Million.

Latest Holdings of Baillie Gifford & Co

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:03347 Hangzhou Tigermed Consulting Co Ltd 2022-02-04 6,167,700 34.95 215,561,115

Holding Weightings of Baillie Gifford & Co


Baillie Gifford & Co Form 4 Trading Tracker

According to the SEC Form 4 filings, Baillie Gifford & Co has made a total of 1 transactions in Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Hangzhou Tigermed Consulting Co Ltd is the sale of 39,000 shares on February 4, 2022, which brought Baillie Gifford & Co around $0.

Insider Trading History of Baillie Gifford & Co

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Baillie Gifford & Co Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Baillie Gifford & Co Ownership Network

Ownership Network List of Baillie Gifford & Co

No Data

Ownership Network Relation of Baillie Gifford & Co

Insider Network Chart

Baillie Gifford & Co Owned Company Details

What does Hangzhou Tigermed Consulting Co Ltd do?

Who are the key executives at Hangzhou Tigermed Consulting Co Ltd?

Baillie Gifford & Co is the 2102 Investment manager of Hangzhou Tigermed Consulting Co Ltd. Other key executives at Hangzhou Tigermed Consulting Co Ltd include 2102 Investment manager yi fang da ji jin guan li you xian gong si , 2101 Beneficial owner Sands Capital Management, LLC , and 2201 Interest of corporation controlled by you Sands Capital Management, LP .

Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) Insider Trades Summary

Over the past 18 months, Baillie Gifford & Co made no insider transaction in Hangzhou Tigermed Consulting Co Ltd (HKSE:03347). Other recent insider transactions involving Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) include a net sale of 470,919 shares made by Jpmorgan Chase & Co. , a net purchase of 614,287 shares made by BlackRock, Inc. , and a net sale of 0 shares made by Citigroup Inc. .

In summary, during the past 3 months, insiders sold 0 shares of Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,186,442 shares of Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) were sold and 6,491,910 shares were bought by its insiders, resulting in a net purchase of 2,305,468 shares.

Hangzhou Tigermed Consulting Co Ltd (HKSE:03347)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Hangzhou Tigermed Consulting Co Ltd Insider Transactions

No Available Data

Baillie Gifford & Co Mailing Address

Above is the net worth, insider trading, and ownership report for Baillie Gifford & Co. Currently GuruFocus does not have mailing address information for Baillie Gifford & Co.

Discussions on Baillie Gifford & Co

No discussions yet.